Fig. 1From: Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledgeMolecular mechanism underlying the antitumor effect of EGCG in Triple Negative breast cancer cells. EGCG: epigallocatechin-3-gallate; PI3K: phosphatidylinositol-3 kinase; EGRF: epidermal growth factor receptor; MARK: mitogen-activated protein kinase; TNF: tumor necrosis factor; ROS: reactive oxygen species; VEGF: vascular endothelial growth factor; FAS: fas cell surface death receptor; CASP1: caspase 1; CASP3: caspase 23; CASP4: caspase 4; TP53: tumor protein p-53; TNBC: triple negativeBack to article page